Replies to post #207755 on Amarin Corp Plc (AMRN)

[Whalatane]

So tell me .... would you be OK with a label covering up to 1/3 rd of the US adult population .... without an Adcom

You seem pretty level headed .
I’ve read your posts for years .

Make the case for why the FDA should grant a label covering up to 1/3 rd of the US adult population .... without an Adcom ..... based solely on R-It data .... of which only about 2,800 were primary prevention at risk of a CV event .

I’ll await your analysis
Thx
Kiwi